Streetbeat News

Partnerships

HOOK

RHHBY

RPTX

Repare Therapeutics Inc (RPTX) announced the termination of its collaboration with Roche Holdings AG (RHHBY) for the development and commercialization of camonsertib (RP-3500), effective May 7, 2024. This decision follows a review of Roche's pipeline and external factors. Repare will regain global rights to camonsertib, which is part of the ongoing Phase 1 MYTHIC trial. Despite this, Repare has received a $40 million milestone payment from Roche and expects its funds to last into mid-2026. This is Roche's second termination within a month, having previously ended a pact with HOOKIPA Pharma Inc (HOOK) for the HB-700 program.

Portfolio Pulse from Vandana Singh

February 13, 2024 | 1:43 pm

LNTH

Lantheus Holdings, Inc. (NASDAQ:LNTH) has entered into a collaboration with the Consortium for Clarity in ADRD Research Through Imaging (CLARiTI) study, sponsored by the National Institute on Aging, to supply MK-6240, a clinical-stage PET imaging agent targeting tau tangles in Alzheimer's disease research. The CLARiTI study, involving all 37 Alzheimer's Disease Research Centers in the U.S., aims to recruit 2,000 subjects to advance understanding and treatment of dementia.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:42 pm

DYAI

Dyadic International, Inc. has partnered with Cygnus Technologies to leverage the newly developed C1 HCP ELISA Kit, which will now be available to both Dyadic and Cygnus customers. This collaboration aims to enhance the biopharmaceutical development process by providing a crucial tool for the efficient and accurate measurement of host cell proteins, a critical aspect of biologic drug development.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:41 pm

CLVR

Clever Leaves Holdings Inc. (NASDAQ:CLVR) and Paradise Seeds have partnered to develop and register high-performance cannabis cultivars in Colombia. Clever Leaves will have an exclusive license to cultivate some genetics, while Paradise will offer others to third parties in Colombia and Latin America. This collaboration, marking the first agronomic registrations of Paradise genetics in Colombia, aims to export Paradise strains to global medicinal cannabis markets. The partnership leverages Paradise's award-winning strains and Clever Leaves' cultivation expertise, aiming to expand Clever Leaves' global footprint and make Paradise varieties available to more patients worldwide.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:40 pm

PALI

Palisade Bio has appointed Donald Williams as the new Chairman of its Board, as part of a strategic streamlining effort to better align with its clinical development and corporate vision. The company is advancing PALI-2108, a treatment for moderate-to-severe ulcerative colitis, towards a Phase 1 clinical study, with the first human study expected to commence before the end of the year.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:40 pm

PINC

Premier, Inc. (PINC) and Datavant are expanding their collaboration to enhance clinical trials by leveraging real-world data and evidence. This partnership aims to improve trial diversity, design, and patient outcomes while reducing costs and time. The collaboration, which began in September 2022, utilizes Datavant's technology to link clinical and real-world data, generating insights that could lead to better patient care and more effective treatments. This effort supports the development of novel therapies by providing a more comprehensive understanding of medical interventions in real-world settings.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:37 pm

ITI

Iteris, Inc. (NASDAQ:ITI) has been awarded a nearly $900,000 contract for a five-month project under the Downey Citywide Bus Signal Priority Project in LA County, California. The project involves installing technology to enable buses to request priority at signalized intersections, aimed at improving traffic flow and ensuring timely transportation for the Downey LINK transit system. This initiative is part of Iteris' Intelligent Transportation Systems (ITS) Build initiative, which focuses on delivering specialized ITS installation services. The project highlights Iteris' ongoing growth and efforts to enhance transportation infrastructure efficiency and robustness in California.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:36 pm

BFLY

TSM

Butterfly Network, Inc. (NYSE:BFLY) announced the commercial launch of Butterfly iQ3, a next-generation handheld ultrasound system with FDA clearance. The iQ3 features advanced P4.3 Ultrasound-on-Chip technology, offering faster data transfer, enhanced frame rates, frequency, and new 3D imaging capabilities. It is now available for purchase in the U.S. The device is designed to improve diagnostic decisions with its high-resolution image quality and advanced imaging tools, including iQ Slice and iQ Fan for 3D imaging. Butterfly iQ3 is developed in collaboration with TSMC (NYSE:TSM), leveraging their semiconductor innovation.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:34 pm

GP

GreenPower Motor Company Inc. (NASDAQ:GP) has secured a $5 million revolving loan from Export Development Canada (EDC) to fund the production of all-electric vehicles for customer orders. This facility, which allows for multiple advances over two years, adds to GreenPower's existing financial resources, including an $8 million operating line of credit and up to $5 million in standby letters of credit from EDC. The funding aims to accelerate the production of electric vehicles without shareholder dilution, supporting GreenPower's growth in the commercial electric vehicle market.

Portfolio Pulse from Happy Mohamed

February 13, 2024 | 1:33 pm

NTGR

NETGEAR, Inc. (NTGR) and Panasonic have announced a partnership to conduct SMPTE ST 2110 testing and compatibility, aiming to enhance the interoperability of their products for professional video production and broadcasting.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:32 pm